Address: PO box 336 Wierda Park 0149 South Africa
Tel: +27 (0)12 668 3021
MC Pharma (Pty) Ltd., is a pharmaceutical company licensed in terms of Section 22C of the Medicines and Related Substances Act 101 of 1965, and offers the services of an Applicant and Holder of the Registration Certificate (Marketing Authorisation holder), on behalf of a Principal or product owner.
MC Pharma does not own, wholesale or distribute product and the Principal is at all times deemed to be the owner of the medicinal product(s). Commercialisation activities are delegated, by means of agreements, to competent and licenced companies in South Africa, with the approval of the Principal or product owner.
MC Pharma is proud to represent, and to service global customers and Principals from such countries as Australia, the USA, Brazil, EU and UK.
1. Reviewing formulation ingredients for claim and labeling compliance;
2. Advertising compliance: avoid the embarrassment and consequences of having a
published advertisement found to be in conflict with local requirements.
We screen promotional material giving confidence that marketing and advertising
complies with local regulatory standards;
3. Regulatory liaison with the Regulatory Authority(ies);
4. GMP and Quality Assurance consultations;
5. GMP assessments of manufacturing, packaging and distribution facilities;
6. Technical agreements with 3rd party contractors: we will facilitate in the setting up of
and establishing the required technical agreements with: –
• Manufacturers and Packers,
• Advertising agencies
• Marketing Agencies
OTHER SERVICES INCLUDE:
In-licensing of products for local commercialisation utilizing Marketing Authorisations under MC Pharma’s name;
Facilitation of product acquisition, including the evaluation of registration dossiers and supporting regulatory and registration documentation;
Product feasibility and positioning;
Market assessment and analysis
Commercialisation of product including marketing;
The South African affiliate was established in June 2003. Could you come back on the main milestones in the…
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South…
Mrs. Reid, how would you define and describe the generic part of the South African pharmaceutical market? Linda…
In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar…